Background: Postnatal growth restriction is very common among preterm infants. Growth restriction might be associated with neurodevelopment impairment. The definition of postnatal growth restriction varies among studies. It has often been based on statistical parameters, but we lack biological data to support this definition. Objectives: The aim here was to study the association between neurodevelopment and postnatal growth restriction defined applying 2 different strategies. Methods: Bayley Scales of Infant Development-II was performed at 2 years corrected age in 168 preterm infants. Postnatal growth restriction was defined as a weight z-score at 36 weeks <–1.5 or treated as a continuous variable (fall in weight z-scores from birth to 36 weeks postmenstrual age). Results: Weight z-scores fell in almost all patients (98.8%), and 44.1% had z-scores <–1.5 at 36 weeks. After adjusting for gestational age and small for gestational age at birth, every 1-point fall in weight z-score was associated with a 5.6 point (95% CI 1.7 to 9.4) decrease in the Mental Developmental Index. A weight z-score <–1.5 at 36 weeks was not associated with a worse mental or psychomotor result. Conclusion: A fall in the weight z-score from birth to 36 weeks is a more rational definition of postnatal growth restriction, and it could predict neurodevelopment.

Keywords:
Growth and development, Infant, Premature, Neurodevelopment
1.
Embleton NE, Pang N, Cooke RJ: Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics 2001; 107: 270–273.
2.
Chan SHT, Johnson MJ, Leaf AA, Vollmer B: Nutrition and neurodevelopmental outcomes in preterm infants: a systematic review. Acta Paediatr 2016; 105: 587–599.
3.
Franz AR, Pohlandt F, Bode H, Mihatsch WA, Sander S, Kron M, et al: Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support. Pediatrics 2009; 123:e101–e109.
4.
Horbar JD, Ehrenkranz RA, Badger GJ, Edwards EM, Morrow KA, Soll RF, et al: Weight growth velocity and postnatal growth failure in infants 501–1,500 grams: 2000–2013. Pediatrics 2015; 136:e84–e92.
5.
Clark RH, Thomas P, Peabody J: Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics 2003; 111: 986–990.
6.
Martin CR, Brown YF, Ehrenkranz RA, O’Shea TM, Allred EN, Belfort MB, et al: Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics 2009; 124: 649–657.
7.
Villar J, Giuliani F, Barros F, Roggero P, Coronado Zarco IA, Rego MAS, et al: Monitoring the postnatal growth of preterm infants: a paradigm change. Pediatrics 2018; 141:e20172467.
8.
Radmacher PG, Looney SW, Rafail ST, Adamkin DH: Prediction of extrauterine growth retardation (EUGR) in VVLBW infants. J Perinatol 2003; 23: 392–395.
9.
Moro Serrano M, Fernández Pérez C, Figueras Alloy J, Pérez Rodríguez J, Coll E, Doménech Martínez E, et al: SEN1500: diseño y desarrollo del registro de niños de menos de 1.500 g al nacer en España. An Pediatría 2008; 68: 181–188.
10.
Sharp M, DeMauro SB: Counterbalanced comparison of the BSID-II and Bayley-III at eighteen to twenty-two months corrected age. J Dev Behav Pediatr 2017; 38: 322–329.
11.
De Pipaón MS, Martínez-Biarge M, Dorronsoro I, Salas S, Madero R, Martos GÁ, et al: Growth in preterm infants until 36 weeks’ postmenstrual age is close to target recommendations. Neonatology 2014; 106: 30–36.
12.
Ramel SE, Brown LD, Georgieff MK: The impact of neonatal illness on nutritional requirements: one size does not fit all. Curr Pediatr Rep 2014; 2: 248–254.
13.
Ehrenkranz RA, Younes N, Lemons JA, Fanaroff AA, Donovan EF, Wright LL, et al: Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999; 104: 280–289.
14.
Ramel SE, Gray HL, Christiansen E, Boys C, Georgieff MK, Demerath EW: Greater early gains in fat-free mass, but not fat mass, are associated with improved neurodevelopment at 1 year corrected age for prematurity in very low birth weight preterm infants. J Pediatr 2016; 173: 108–115.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.